FA
Forefront Analytics Portfolio holdings
AUM
$89.5M
1-Year Return
11.48%
This Quarter Return
+6.93%
1 Year Return
+11.48%
3 Year Return
+24.94%
5 Year Return
+31.9%
10 Year Return
–
AUM
$188M
AUM Growth
-$119K
(-0.06%)
Cap. Flow
-$12.6M
Cap. Flow
% of AUM
-6.74%
Top 10 Holdings %
Top 10 Hldgs %
60.18%
Holding
81
New
15
Increased
22
Reduced
35
Closed
6
Top Buys
Top Sells
| 1 |
Nuveen ESG Large-Cap Value ETF
NULV
|
$5.92M |
| 2 |
iShares Currency Hedged MSCI Emerging Markets
HEEM
|
$4.93M |
| 3 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$3.82M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$1.83M |
| 5 |
iShares Core High Dividend ETF
HDV
|
$1.32M |
Sector Composition
| 1 | Healthcare | 1.26% |
| 2 | Industrials | 0.26% |
| 3 | Financials | 0.24% |
| 4 | Technology | 0.19% |
| 5 | Real Estate | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Johnson & Johnson
JNJ
$431B
| – | – |
-1,868
| Closed | -$307K |
|
77
Kinross Gold
KGC
$26.2B
| – | – |
-16,000
| Closed | -$60K |
|
|
VRNA
78
Verona Pharma
VRNA
$9.19B
| – | – |
-13,446
| Closed | -$138K |
|
|
THRX
79
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| – | – |
-13,065
| Closed | -$74K |
|
|
PRVB
80
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| – | – |
-14,997
| Closed | -$68K |
|
81
Alamos Gold
AGI
$13.3B
| – | – |
-14,250
| Closed | -$106K |
|